M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns

Slides:



Advertisements
Similar presentations
Port-site recurrence in a patient undergoing robotic hysterectomy and lymph node dissection for endometrioid adenocarcinoma of the uterus Ioannis Alagkiozidis,
Advertisements

Port site metastasis after robotic-assisted laparoscopic hysterectomy for uterine cervical cancer: A case report and literature review BoKyong Kim, Seung.
Volume 144, Issue 1, Pages (January 2017)
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.
Volume 148, Issue 1, Pages (January 2018)
Influence of robotic-assisted laparoscopic hysterectomy on vaginal cuff healing and brachytherapy initiation in endometrial carcinoma patients  John M.
Volume 150, Issue 1, Pages (July 2018)
Volume 148, Issue 1, Pages (January 2018)
Are patients willing to travel for better ovarian cancer care?
Volume 148, Issue 1, Pages (January 2018)
L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L
Volume 148, Issue 1, Pages (January 2018)
A. Melamed, E. J. Diver, A. A. Gockley, E. M. Hinchcliff, L
Volume 145, Issue 2, Pages (May 2017)
Volume 138, Issue 1, Pages (July 2015)
Vulvar intraepithelial neoplasia: Risk factors for recurrence
Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008]  Douglas.
Amr Mohammad Allama, MD  The Annals of Thoracic Surgery 
Characteristics of pain in hospitalized medical patients, surgical patients, and outpatients attending a pain management centre  M.P. Rockett, G. Simpson,
Type of anaesthesia and patient quality of recovery: a randomized trial comparing propofol–remifentanil total i.v. anaesthesia with desflurane anaesthesia 
The efficacy of mTORC1/2 inhibition on ovarian cancer stem cells
Ali F. AbuRahma, MD  Journal of Vascular Surgery 
Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei 
Supportive care plans: Linking patient-reported outcomes to evidence-based supportive care across the cancer continuum  E.E. Stevens, J.N. Bottsford-Miller,
L.M. Bean, F.J. Sulzmaier, D.D. Schlaepfer
Volume 142, Issue 3, Pages (September 2016)
National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence  J. Chino, J.R. Foote,
Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer  E.N. Prendergast,
K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani
Volume 152, Issue 1, Pages (January 2019)
Volume 143, Issue 2, Pages (November 2016)
Laparoscopic staging for stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base  A. Melamed, J.T. Clemmer, N.L. Keating, J.D. Wright,
The origins of multidisciplinary cancer care
Adherence to hematologic hold parameters in dose-dense chemotherapy for ovarian malignancies: A survey of the National Comprehensive Cancer Network (NCCN)
Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM)  C. Popadiuk, A.J. Coldman,
I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M
Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum  A. Ellis, M.K. Frey, L.M. Koontz, S. Shyne,
Volume 152, Issue 1, Pages (January 2019)
Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates  N.A. Latif, E.M. Ko,
Volume 152, Issue 1, Pages (January 2019)
Volume 147, Issue 1, Pages (October 2017)
Lise L. Kjaergard, Sarah L. Frederiksen, Christian Gluud 
Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK , an AKT inhibitor, in patients with recurrent or persistent.
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
The complex interaction of cancer surgery, complications, and patient-reported outcomes: A single score is not enough  K.M. Doll, E.L. Barber, J.T. Bensen,
Volume 142, Issue 2, Pages (August 2016)
Annika Idahl, Andrea Hermansson, Ann Lalos  Gynecologic Oncology 
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study 
Volume 152, Issue 1, Pages (January 2019)
Full inguinofemoral lymphadenectomy after positive sentinel inguinofemoral lymph node is associated with greater overall survival in patients with stage.
Volume 152, Issue 1, Pages (January 2019)
Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer  M. Dandapani, B.L. Seagle, R. Samuelson,
Volume 130, Issue 1, Pages (July 2013)
Evaluation of diagnostic tests
GlideScope® video laryngoscope: a randomized clinical trial in 203 paediatric patients†   J.-T. Kim, H.-S. Na, J.-Y. Bae, D.-W. Kim, H.-S. Kim, C.S. Kim,
Use of Barbed Suture in Robot-Assisted Mitral Valvuloplasty
Characteristics of primary peritoneal serous carcinoma in a U. S
Volume 152, Issue 1, Pages (January 2019)
Table of Contents Nurse Leader Volume 16, Issue 3, (June 2018)
Volume 147, Issue 3, Pages (December 2017)
Volume 124, Issue 1, Pages (January 2012)
High-risk cancer, unequal care: Disparities in the complete surgical staging of high- grade endometrial cancer in the Southeastern United States  J.R.
Should ovarian preservation be considered for women younger than 60 years with endometrial carcinoma?  L.M. Bean, K. Taylor, K.M. Anderson, M.A. Davis,
Volume 2, Issue 6, Pages (June 2017)
The Propranolol Aneurysm Trial Investigators 
Volume 115, Issue 1, Pages (October 2009)
Volume 153, Issue 3, Pages (June 2019)
Volume 153, Issue 3, Pages (June 2019)
Volume 154, Issue 2, Pages (August 2019)
Volume 154, Issue 1, Pages (July 2019)
Presentation transcript:

M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns Vaginal cuff closure in robotic hysterectomy: A randomized controlled trial comparing barbed versus standard suture  M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns  Gynecologic Oncology  Volume 141, Pages 83-84 (June 2016) DOI: 10.1016/j.ygyno.2016.04.234 Copyright © 2015 Terms and Conditions

Fig. 1 Patient Selection. Gynecologic Oncology 2016 141, 83-84DOI: (10.1016/j.ygyno.2016.04.234) Copyright © 2015 Terms and Conditions